Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-756-6 | CAS number: 87-60-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions (5th strain is missing, which has an AT base pair at the primary reversion site. 2-Aminoanthracene is used as the sole indicator of the efficacy of the S9-mix.)
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Unnamed
- Year:
- 1 996
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 3-chloro-o-toluidine
- EC Number:
- 201-756-6
- EC Name:
- 3-chloro-o-toluidine
- Cas Number:
- 87-60-5
- Molecular formula:
- C7H8ClN
- IUPAC Name:
- 3-chloro-2-methylaniline
Constituent 1
Method
- Target gene:
- his operon
Species / strain
- Species / strain / cell type:
- S. typhimurium, other: TA 97, TA 98, TA 100 and TA 1535
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats and syrian hamster treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- 0, 3, 10, 33, 100, 333, 666, 1000 µg/plate for strains TA 97 and TA 1535
0, 3, 10, 33, 100, 333, 666, 1000, 1666 µg/plate for strains TA 98 and TA 100 - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 2-nitrofluorene or 4-nitro-o-phenylenediamine (TA 98); sodium azide (TA 100 and TA 1535); 9-aminoacridine (TA 97)
- Remarks:
- without S9 mix
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene (all strains)
- Remarks:
- with S9 mix
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 minutes at 37°C
- Exposure duration: 48 hours
Results and discussion
Test results
- Species / strain:
- S. typhimurium, other: TA 97, TA 98, TA 100 and TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- in the highest concentrations tested (see table)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
TA 100
Dose |
No Activation |
No Activation |
10% HLI |
30% HLI |
10% RLI |
30% RLI |
|||||||
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
||||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
|||||||
µg/Plate |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
|
0 |
128 |
3.3 |
118 |
7.2 |
123 |
8 |
109 |
3 |
127 |
6.1 |
111 |
3.7 |
|
3 |
|
|
119 |
4 |
|
|
|
|
|
|
|
|
|
10 |
113 |
8.3 |
116 |
2.4 |
118 |
10.8 |
|
|
109 |
3.2 |
|
|
|
33 |
115 |
7.5 |
112 |
2.7 |
116 |
11.8 |
106 |
3.5 |
122 |
4.8 |
113 |
4.6 |
|
100 |
96 |
6.5 |
110 |
3.8 |
130 |
6.4 |
107 |
4.2 |
109 |
14.6 |
108 |
4.3 |
|
333 |
116 |
3.3 |
94 |
5 |
133 |
12.7 |
108 |
5.5 |
131 |
9.5 |
103 |
5.8 |
|
666 |
0x |
0 |
|
|
100 |
1.2 |
|
|
113 |
3 |
|
|
|
1000 |
|
|
|
|
|
|
104 |
4.2 |
|
|
106 |
1.5 |
|
1666 |
|
|
|
|
|
|
t |
|
|
|
t |
|
|
Positive Control |
837 |
14.4 |
945 |
32.2 |
926 |
38.5 |
559 |
21.4 |
528 |
7.5 |
437 |
10.6 |
TA 1535
Dose |
No Activation |
No Activation |
10% HLI |
30% HLI |
10% RLI |
30% RLI |
|||||||
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
||||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
|||||||
µg/Plate |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
|
0 |
11 |
1.5 |
9 |
1.7 |
13 |
1,5 |
10 |
1.9 |
16 |
2.3 |
11 |
1 |
|
3 |
8 |
1.5 |
11 |
0.3 |
|
|
|
|
|
|
|
|
|
10 |
8 |
0.9 |
8 |
1.5 |
15 |
2.3 |
11 |
1 |
14 |
1.5 |
9 |
0.7 |
|
33 |
7 |
0.6 |
10 |
1.5 |
12 |
1.2 |
9 |
1.2 |
12 |
1.5 |
9 |
0.9 |
|
100 |
8 |
1.5 |
10 |
0.7 |
11 |
1.8 |
10 |
1.9 |
10 |
0.7 |
7 |
1 |
|
333 |
7 |
1 |
8 |
0.7 |
15 |
2.3 |
10 |
2.1 |
11 |
1.9 |
7 |
0.3 |
|
666 |
|
|
|
|
6 |
0.9 |
|
|
4 |
0.6 |
|
|
|
1000 |
|
|
|
|
|
|
7 |
0.9 |
|
|
4s |
0.6 |
|
Positive Control |
877 |
21.1 |
907 |
46.4 |
149 |
6.7 |
259 |
19.7 |
124 |
9.5 |
138 |
10.1 |
TA 97
Dose |
No Activation |
No Activation |
10% HLI |
30% HLI |
10% RLI |
30% RLI |
|||||||
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
||||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
|||||||
µg/Plate |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
|
0 |
160 |
9.9 |
135 |
6.1 |
132 |
13.9 |
170 |
7.2 |
157 |
11 |
186 |
4.6 |
|
3 |
168 |
9.7 |
127 |
7 |
|
|
|
|
|
|
|
|
|
10 |
170 |
8.8 |
139 |
0.9 |
137 |
9.2 |
176 |
7 |
135 |
11 |
181 |
4.7 |
|
33 |
176 |
9.9 |
143 |
7.3 |
156 |
15.9 |
180 |
8.1 |
159 |
9.9 |
187 |
6 |
|
100 |
183 |
6.2 |
120 |
9.8 |
151 |
5 |
174 |
11.5 |
158 |
14.7 |
179 |
8.3 |
|
333 |
188 |
7 |
98 |
0.9 |
140 |
12.4 |
181 |
9 |
178 |
5.5 |
176 |
10.4 |
|
666 |
|
|
|
|
118 |
5.5 |
|
|
108 |
1,2 |
|
|
|
1000 |
|
|
|
|
|
|
179 |
4.7 |
|
|
56s |
8.9 |
|
Positive Control |
581 |
18 |
583 |
58.3 |
1008 |
27.5 |
508 |
6.1 |
647 |
20,7 |
447 |
15.7 |
TA 98
Dose |
No Activation |
No Activation |
10% HLI |
30% HLI |
10% RLI |
30% RLI |
|||||||
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
(Negative) |
||||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
|||||||
µg/Plate |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
Mean |
± SEM |
|
0 |
17 |
2 |
22 |
3.5 |
21 |
2.9 |
21 |
2.3 |
24 |
3.2 |
18 |
2.8 |
|
3 |
|
|
24 |
3.2 |
|
|
|
|
|
|
|
|
|
10 |
18 |
0.3 |
26 |
1.2 |
16 |
1.9 |
|
|
26 |
3.3 |
|
|
|
33 |
20 |
2.9 |
20 |
0.7 |
18 |
1.7 |
22 |
3.3 |
22 |
1 |
18 |
2.7 |
|
100 |
18 |
1.5 |
24 |
3.5 |
24 |
3.2 |
20 |
2.9 |
27 |
1.7 |
22 |
2.1 |
|
333 |
18 |
2.1 |
25 |
5.5 |
22 |
3.2 |
19 |
2.6 |
24 |
2.1 |
16 |
1.5 |
|
666 |
x |
|
|
|
18 |
4.3 |
|
|
22 |
6.2 |
|
|
|
1000 |
|
|
|
|
|
|
17 |
2.2 |
|
|
15 |
1.2 |
|
1666 |
|
|
|
|
|
|
t |
|
|
|
t |
|
|
Positive Control |
336 |
11 |
387 |
10 |
760 |
26.9 |
534 |
13.2 |
438 |
25.5 |
514 |
6.7 |
Abbreviations:
RLI = induced male Sprague Dawley rat liver S9
HLI = induced male Syrian hamster liver S9
s = Slight Toxicity; p = Precipitate; x = Slight Toxicity and Precipitate; T = Toxic; c = ContaminationApplicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
